일차 세포배양 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형별, 세포 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Primary Cell Culture Market Summary

The global primary cell culture market size was estimated at USD 5.25 billion in 2025 and is projected to reach USD 12.45 billion by 2033, expanding at a CAGR of 11.6% from 2026 to 2033. The market expansion is largely driven by the rising burden of chronic diseases, increased government funding for cell-based research, and the continued growth of the pharmaceutical and biotechnology sectors.

Rising usage of primary cell culture products in in-vitro testing and drug screening

The increasing demand for primary cell culture products in laboratory testing and drug evaluation processes drives market growth because these cells provide better human tissue simulation than permanent cell lines. The native genetic and functional characteristics of their cells enable more precise assessment of toxicity and efficacy, and mechanism-of-action research, which helps pharmaceutical and biotechnology companies decrease their costs associated with late-stage drug development and drug failure rates.

Global Primary Cell Culture Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the primary cell culture market based on product, cell type, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Primary Cells
  • Hematopoietic Cells
  • Skin Cells
  • Hepatocytes
  • Gastrointestinal Cells
  • Lung Cells
  • Renal Cells
  • Heart Cells
  • Skeletal and Muscle Cells
  • Other Primary Cells
• Media
  • Serum-free Media
  • Serum-containing Media
  • Others
• Reagents and Supplements
  • Attachment Solutions
  • Buffers and Salts
  • Freezing Media
  • Sera
  • Growth Factors and Cytokines
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cell & Gene Therapy Development
• Vaccine Production
• Model System
• Virology
• Prenatal Diagnosis
• Others
• Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
• Human Cells
• Animal Cells
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• CMOs & CROs
• Academic Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Cell Type Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
    • 3.2.1.2. Increasing demand for stem cell therapy and regenerative medicine
    • 3.2.1.3. Rising incidence of cancer and other chronic diseases
    • 3.2.1.4. Advancement in genetic engineering protocols
    • 3.2.1.5. Rise in research funding for functional biology and research
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Ethical and regulatory concerns related with the use of primary cells
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Primary Cell Culture Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Primary Cell Culture Market Product Movement Analysis
• 4.3. Global Primary Cell Culture Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Primary Cells
  • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Hematopoietic Cells
    • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Skin Cells
    • 4.4.3.1. Skin cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.4. Hepatocytes
    • 4.4.4.1. Hepatocytes market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Gastrointestinal Cells
    • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.6. Lung Cells
    • 4.4.6.1. Lung cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.7. Renal Cells
    • 4.4.7.1. Renal cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.8. Heart Cells
    • 4.4.8.1. Heart cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.9. Skeletal and Muscle Cells
    • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.10. Other Primary Cells
    • 4.4.10.1. Other primary cells market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Media
  • 4.5.1. Global Media Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Serum-free Media
    • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Serum-containing Media
    • 4.5.3.1. Global Serum-containing Media Market and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Other Media
    • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Reagents and Supplements
  • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Attachment Solutions
    • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. Buffers and Salts
    • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Sera
    • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.5. Growth Factors and Cytokines
    • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.6. Freezing Media
    • 4.6.6.1. Global Freezing Media Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.7. Others
    • 4.6.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Primary Cell Culture Market Application, Movement Analysis
• 5.3. Global Primary Cell Culture Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Vaccine Production
  • 5.4.1. Global Vaccine Production Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Cell & Gene Therapy Development
  • 5.5.1. Global Cell & Gene Therapy Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Model System
  • 5.6.1. Global Model System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Virology
  • 5.7.1. Global Virology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Prenatal Diagnosis
  • 5.8.1. Global Prenatal Diagnosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Global Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Primary Cell Culture Market: Cell Type Business Analysis

• 6.1. Cell Type Segment Dashboard
• 6.2. Global Primary Cell Culture Market Cell Type Movement Analysis
• 6.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Human Cells
  • 6.4.1. Global Human Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Animal Cells
  • 6.5.1. Global Animal Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Primary Cell Culture Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Primary Cell Culture Market End Use Movement Analysis
• 7.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. CMOs & CROs
  • 7.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Academic Research Institutes
  • 7.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Primary Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Participant's Overview
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. STEMCELL Technologies
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Merck KGaA
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Lonza
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Cell Biologics, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. PromoCell GMBH
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. ZenBio
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. AllCells
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. American Type Culture Collection
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Axol Biosciences Ltd.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives